Figure 1. Cumulative Incidence of Myocarditis after BNT162b2 Vaccination among Israeli Adolescents 12 to 15 Years of Age.

Shown is the cumulative incidence of myocarditis during a 42-day period after the receipt of the first dose of the BNT162b2 vaccine in Israel among 182,605 vaccinated adolescents between the ages of 12 and 15 years of age who were enrolled in the Clalit Health Services. A diagnosis of myocarditis was made in 9 patients. The vertical dashed line at 21 days indicates the median day of administration of the second vaccine dose. The shaded area represents the 95% confidence interval.